Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Mohammed Orloff

Concepts (234)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hamartoma Syndrome, Multiple
8
2012
16
1.130
 Why?
Germ-Line Mutation
9
2013
68
1.130
 Why?
PTEN Phosphohydrolase
13
2015
61
1.090
 Why?
Barrett Esophagus
2
2019
28
1.070
 Why?
Genetic Predisposition to Disease
10
2021
570
1.070
 Why?
Esophageal Neoplasms
2
2019
100
0.990
 Why?
Adenocarcinoma
3
2019
428
0.870
 Why?
Haplotypes
3
2020
105
0.810
 Why?
Homozygote
3
2019
60
0.700
 Why?
Polymorphism, Single Nucleotide
9
2021
552
0.690
 Why?
Carcinoma, Non-Small-Cell Lung
1
2020
164
0.660
 Why?
Proto-Oncogene Proteins c-akt
4
2012
176
0.620
 Why?
Databases, Factual
1
2020
683
0.600
 Why?
Alleles
6
2021
277
0.480
 Why?
Lung Neoplasms
3
2020
643
0.470
 Why?
Phosphatidylinositol 3-Kinases
2
2012
153
0.440
 Why?
Genotype
6
2021
600
0.420
 Why?
Scavenger Receptors, Class A
1
2011
38
0.400
 Why?
Extracellular Matrix Proteins
1
2011
75
0.400
 Why?
Genetic Variation
3
2021
253
0.310
 Why?
Transcription Factors
1
2011
622
0.300
 Why?
Breast Neoplasms
7
2017
1249
0.300
 Why?
Thyroid Neoplasms
4
2012
162
0.290
 Why?
Humans
36
2024
54391
0.280
 Why?
Genes, Wilms Tumor
1
2005
2
0.260
 Why?
Population
1
2005
10
0.260
 Why?
Glomerulosclerosis, Focal Segmental
1
2005
17
0.260
 Why?
Gene Frequency
3
2020
120
0.260
 Why?
Genome
2
2019
74
0.250
 Why?
Capacity Building
1
2024
19
0.240
 Why?
Case-Control Studies
3
2020
1229
0.230
 Why?
Linkage Disequilibrium
2
2020
47
0.230
 Why?
Middle Aged
16
2021
13082
0.220
 Why?
Smoke-Free Policy
1
2022
9
0.220
 Why?
Tobacco Smoke Pollution
1
2022
56
0.210
 Why?
Adult
15
2021
14207
0.200
 Why?
Female
20
2022
28471
0.200
 Why?
Inheritance Patterns
1
2021
27
0.200
 Why?
Phenotype
7
2021
819
0.190
 Why?
Models, Genetic
5
2013
209
0.190
 Why?
Succinate Dehydrogenase
2
2011
28
0.190
 Why?
Risk Factors
5
2019
3937
0.180
 Why?
Stilbenes
2
2010
65
0.180
 Why?
Fires
1
2020
19
0.180
 Why?
Agriculture
1
2020
24
0.180
 Why?
Aged
11
2020
10060
0.180
 Why?
Social Media
1
2021
105
0.170
 Why?
Tobacco Products
1
2021
115
0.170
 Why?
Cluster Analysis
4
2013
249
0.170
 Why?
Exome
1
2019
51
0.170
 Why?
Aged, 80 and over
5
2020
3431
0.170
 Why?
Male
14
2021
27347
0.160
 Why?
Genomics
1
2020
313
0.160
 Why?
Cell Proliferation
3
2010
1097
0.160
 Why?
Pulmonary Disease, Chronic Obstructive
1
2020
133
0.150
 Why?
Prostatic Neoplasms
2
2012
421
0.150
 Why?
Gene Expression Regulation, Neoplastic
3
2010
868
0.150
 Why?
Prognosis
2
2020
2126
0.140
 Why?
Endometrial Neoplasms
2
2015
145
0.140
 Why?
Leprosy
1
2016
6
0.140
 Why?
Asthma
1
2020
293
0.140
 Why?
Hypertension
1
2021
565
0.140
 Why?
Microsatellite Repeats
2
2012
46
0.130
 Why?
Emergency Service, Hospital
1
2020
543
0.130
 Why?
Regression Analysis
2
2017
445
0.130
 Why?
Aromatase
1
2015
8
0.130
 Why?
Tuberculosis
1
2016
104
0.130
 Why?
Heart Defects, Congenital
1
2021
608
0.130
 Why?
Arkansas
4
2024
2100
0.120
 Why?
Genetic Linkage
2
2011
26
0.120
 Why?
Sirolimus
2
2010
65
0.120
 Why?
Young Adult
7
2021
4318
0.120
 Why?
Bone Morphogenetic Protein Receptors, Type I
1
2013
2
0.110
 Why?
Smad4 Protein
1
2013
6
0.110
 Why?
Genome-Wide Association Study
2
2012
190
0.110
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2012
17
0.110
 Why?
Adolescent
8
2021
6900
0.110
 Why?
Genetic Testing
2
2010
135
0.110
 Why?
Cohort Studies
3
2012
1546
0.110
 Why?
Colonic Polyps
1
2013
43
0.110
 Why?
Receptors, Cell Surface
1
2013
130
0.110
 Why?
Codon, Nonsense
1
2012
29
0.100
 Why?
Flavin-Adenine Dinucleotide
1
2011
5
0.100
 Why?
NAD
1
2011
46
0.100
 Why?
Genes, p53
1
2011
60
0.100
 Why?
Antigens, CD
1
2013
242
0.100
 Why?
Mutation, Missense
1
2012
117
0.100
 Why?
DNA, Neoplasm
1
2012
171
0.100
 Why?
Siblings
1
2011
38
0.100
 Why?
Taxoids
1
2011
45
0.100
 Why?
Risk
1
2012
343
0.100
 Why?
Mitochondrial Diseases
1
2012
109
0.100
 Why?
Adenoma
1
2012
142
0.100
 Why?
Gene Expression Profiling
3
2012
1141
0.100
 Why?
Colorectal Neoplasms
2
2012
237
0.100
 Why?
Intestinal Polyps
1
2010
9
0.090
 Why?
Tumor Microenvironment
1
2012
210
0.090
 Why?
Software
1
2013
297
0.090
 Why?
Cephalometry
1
2010
21
0.090
 Why?
Receptors, Androgen
1
2010
49
0.090
 Why?
Head
1
2010
78
0.090
 Why?
Gene Dosage
1
2009
92
0.090
 Why?
Carcinoma, Transitional Cell
1
2010
54
0.090
 Why?
Intracellular Signaling Peptides and Proteins
1
2010
151
0.090
 Why?
Cell Communication
1
2009
72
0.090
 Why?
Drug Resistance, Neoplasm
1
2011
309
0.090
 Why?
Patient Selection
1
2010
284
0.080
 Why?
Urinary Bladder Neoplasms
1
2010
173
0.080
 Why?
Age Factors
1
2012
1199
0.080
 Why?
Immunohistochemistry
1
2011
1090
0.080
 Why?
Smoking
1
2012
552
0.080
 Why?
Chromosome Mapping
2
2021
175
0.070
 Why?
Prevalence
2
2021
1025
0.070
 Why?
Prospective Studies
4
2017
2606
0.070
 Why?
Mass Screening
1
2010
370
0.070
 Why?
Rural Population
2
2022
598
0.070
 Why?
Physical Chromosome Mapping
1
2005
9
0.070
 Why?
Cell Line, Tumor
4
2011
1551
0.070
 Why?
Multiple Myeloma
1
2020
3049
0.070
 Why?
Frasier Syndrome
1
2005
1
0.070
 Why?
Denys-Drash Syndrome
1
2005
3
0.070
 Why?
Antineoplastic Agents
2
2011
1300
0.070
 Why?
Exons
1
2005
105
0.060
 Why?
Child
5
2020
7368
0.060
 Why?
Models, Theoretical
1
2005
184
0.060
 Why?
Gene Expression Regulation
1
2008
1063
0.060
 Why?
Polyproteins
1
2022
2
0.060
 Why?
Mutation
2
2010
1504
0.050
 Why?
Biopsy
1
2005
692
0.050
 Why?
DNA Methylation
2
2020
575
0.050
 Why?
Phosphoproteins
1
2022
116
0.050
 Why?
Child, Preschool
3
2020
4158
0.050
 Why?
RNA, Viral
1
2022
141
0.050
 Why?
Risk Assessment
2
2021
1362
0.050
 Why?
Cardiomyopathy, Hypertrophic, Familial
1
2021
6
0.050
 Why?
United States Food and Drug Administration
1
2021
97
0.050
 Why?
Azacitidine
1
2020
37
0.050
 Why?
Membrane Glycoproteins
1
2022
270
0.050
 Why?
Nutrition Surveys
1
2021
122
0.050
 Why?
Loss of Heterozygosity
2
2012
97
0.050
 Why?
Stromal Cells
2
2012
79
0.050
 Why?
TOR Serine-Threonine Kinases
2
2010
85
0.050
 Why?
United States
2
2021
5208
0.050
 Why?
Self Report
1
2021
205
0.050
 Why?
Nicotine
1
2021
205
0.040
 Why?
Pedigree
2
2010
146
0.040
 Why?
Seasons
1
2020
98
0.040
 Why?
Air Pollution
1
2020
45
0.040
 Why?
Odds Ratio
1
2021
600
0.040
 Why?
Signal Transduction
3
2010
1752
0.040
 Why?
Neoplasms
1
2009
1322
0.040
 Why?
Sensitivity and Specificity
2
2012
922
0.040
 Why?
Phosphorylation
2
2010
613
0.040
 Why?
Gene Expression
2
2012
664
0.040
 Why?
Dexamethasone
1
2020
435
0.040
 Why?
Predictive Value of Tests
2
2012
1045
0.040
 Why?
Treatment Outcome
2
2020
5612
0.040
 Why?
Angiopoietin-2
1
2017
16
0.040
 Why?
Angiopoietin-1
1
2017
18
0.040
 Why?
Receptor, TIE-2
1
2017
18
0.040
 Why?
Fibroblast Growth Factor 2
1
2017
33
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2017
51
0.040
 Why?
Infant
2
2020
3829
0.040
 Why?
Dose-Response Relationship, Drug
2
2010
1476
0.040
 Why?
Matrix Metalloproteinase 9
1
2017
93
0.040
 Why?
Neoadjuvant Therapy
1
2017
125
0.030
 Why?
Vascular Endothelial Growth Factor A
1
2017
232
0.030
 Why?
Cross-Sectional Studies
1
2021
1696
0.030
 Why?
Neovascularization, Pathologic
1
2017
168
0.030
 Why?
HapMap Project
1
2015
3
0.030
 Why?
Introns
1
2015
49
0.030
 Why?
Antineoplastic Combined Chemotherapy Protocols
1
2020
1060
0.030
 Why?
Peutz-Jeghers Syndrome
1
2013
2
0.030
 Why?
Pilot Projects
1
2016
807
0.030
 Why?
Databases, Genetic
1
2013
101
0.030
 Why?
Genome, Human
1
2013
131
0.030
 Why?
Validation Studies as Topic
1
2012
10
0.030
 Why?
Penetrance
1
2012
7
0.030
 Why?
Neoplasm Grading
1
2012
131
0.030
 Why?
Anthracyclines
1
2011
25
0.020
 Why?
Genetic Association Studies
1
2012
136
0.020
 Why?
Vincristine
1
2011
98
0.020
 Why?
Formazans
1
2010
4
0.020
 Why?
Inhibitory Concentration 50
1
2010
80
0.020
 Why?
Tetrazolium Salts
1
2010
17
0.020
 Why?
Immunoblotting
1
2010
134
0.020
 Why?
Androgen Antagonists
1
2010
15
0.020
 Why?
Paclitaxel
1
2011
103
0.020
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
101
0.020
 Why?
Drug Synergism
1
2010
171
0.020
 Why?
HEK293 Cells
1
2011
245
0.020
 Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2010
19
0.020
 Why?
Michigan
1
2010
36
0.020
 Why?
Neoplasm Transplantation
1
2010
94
0.020
 Why?
Androgens
1
2010
68
0.020
 Why?
Transplantation, Heterologous
1
2010
76
0.020
 Why?
Mitogen-Activated Protein Kinases
1
2010
170
0.020
 Why?
Point Mutation
1
2010
92
0.020
 Why?
Heredity
1
2009
1
0.020
 Why?
Endoscopy, Gastrointestinal
1
2010
75
0.020
 Why?
Epithelial Cells
1
2012
255
0.020
 Why?
BRCA2 Protein
1
2009
23
0.020
 Why?
Adenosine Triphosphate
1
2011
242
0.020
 Why?
Comparative Genomic Hybridization
1
2009
50
0.020
 Why?
Kidney Neoplasms
1
2012
197
0.020
 Why?
BRCA1 Protein
1
2009
40
0.020
 Why?
Mice, Nude
1
2010
284
0.020
 Why?
Polymerase Chain Reaction
1
2011
531
0.020
 Why?
Proteins
1
2012
376
0.020
 Why?
Chi-Square Distribution
1
2010
318
0.020
 Why?
Cell Cycle
1
2010
275
0.020
 Why?
Gene Deletion
1
2010
293
0.020
 Why?
Protein Binding
1
2011
736
0.020
 Why?
Algorithms
1
2013
697
0.020
 Why?
Diagnosis, Differential
1
2012
1141
0.020
 Why?
Cell Survival
1
2010
657
0.020
 Why?
Neoplasm Invasiveness
1
2009
294
0.020
 Why?
Neoplastic Stem Cells
1
2009
104
0.020
 Why?
Incidence
1
2012
1083
0.020
 Why?
Cell Transformation, Neoplastic
1
2009
200
0.020
 Why?
Neoplasm Staging
1
2011
805
0.020
 Why?
Microscopy, Confocal
1
2008
110
0.020
 Why?
Promoter Regions, Genetic
1
2010
520
0.020
 Why?
Membrane Proteins
1
2010
389
0.020
 Why?
Oligonucleotide Array Sequence Analysis
1
2009
474
0.020
 Why?
Cell Differentiation
1
2011
720
0.020
 Why?
Chromosome Aberrations
1
2009
316
0.020
 Why?
Survival Rate
1
2010
954
0.020
 Why?
Registries
1
2010
553
0.020
 Why?
Chromosomes, Human
1
2005
45
0.020
 Why?
Time Factors
1
2010
3210
0.010
 Why?
Reproducibility of Results
1
2005
1301
0.010
 Why?
Mice
1
2010
6428
0.010
 Why?
Animals
1
2010
14409
0.010
 Why?
Orloff's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (234) concept(s)
_
Co-Authors Expand Description
See all (23) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department